{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:28:32Z","timestamp":1776918512875,"version":"3.51.2"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1634\/theoncologist.2012-0320","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T04:15:13Z","timestamp":1365653713000},"page":"e16-e17","source":"Crossref","is-referenced-by-count":26,"title":["Geographic Tongue Induced by Angiogenesis Inhibitors"],"prefix":"10.1093","volume":"18","author":[{"given":"Thomas","family":"Hubiche","sequence":"first","affiliation":[{"name":"a Dermatology, Centre Hospitalier Intercommunal, Frejus-Saint Raphael, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Valenza","sequence":"additional","affiliation":[{"name":"b Oncology Departments, Centre Hospitalier Intercommunal, Frejus-Saint Raphael, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Chevreau","sequence":"additional","affiliation":[{"name":"c Oncology, Claudius Regaud Institute, Toulouse, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Fricain","sequence":"additional","affiliation":[{"name":"e Odontology Department, Pellegrin University Hospital, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Del Giudice","sequence":"additional","affiliation":[{"name":"a Dermatology, Centre Hospitalier Intercommunal, Frejus-Saint Raphael, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[{"name":"d Dermatology Departments, Claudius Regaud Institute, Toulouse, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"2021122308264488200_B1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1634\/theoncologist.2011-0198","article-title":"Characteristics of oral mucosal events related to bevacizumab treatment","volume":"17","author":"Gavrilovic","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308264488200_B2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9343(02)01379-7","article-title":"Benign migratory glossitis or geographic tongue: an enigmatic oral lesion","volume":"113","author":"Assimakopoulos","year":"2002","journal-title":"Am J Med"},{"key":"2021122308264488200_B3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","article-title":"Vascular endothelial growth factor localization in the adult","volume":"168","author":"Maharaj","year":"2006","journal-title":"Am J Pathol"},{"key":"2021122308264488200_B4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/1940-6207.CAPR-10-0135","article-title":"inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis","volume":"3","author":"Zhou","year":"2010","journal-title":"Cancer Prev Res"},{"key":"2021122308264488200_B5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/theoncologist.2011-0111","article-title":"Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review","volume":"17","author":"Boers-Doets","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308264488200_B6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2133.2009.09290.x","article-title":"Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib","volume":"161","author":"Lee","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2012-0320","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0320","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/e16\/41856109\/oncolo_18_4_e16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/e16\/41856109\/oncolo_18_4_e16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:29:15Z","timestamp":1640248155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/4\/e16\/6398718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,10]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0320","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4,1]]},"published":{"date-parts":[[2013,4,1]]}}}